613 related articles for article (PubMed ID: 11164771)
21. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
[TBL] [Abstract][Full Text] [Related]
22. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway.
Annett LE; Martel FL; Rogers DC; Ridley RM; Baker HF; Dunnett SB
Exp Neurol; 1994 Feb; 125(2):228-46. PubMed ID: 7906227
[TBL] [Abstract][Full Text] [Related]
23. Morphological and functional evidence for enhanced growth and potassium-evoked dopamine release in striatal grafts innervated with a patchy growth pattern. An in oculo nigrostriatal cograft study.
Vidal N; Björklund L; Strömberg I
Cell Transplant; 1998; 7(2):97-108. PubMed ID: 9588592
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease.
Mendez I; Baker KA; Hong M
Brain Res Brain Res Rev; 2000 Apr; 32(1):328-39. PubMed ID: 10751681
[TBL] [Abstract][Full Text] [Related]
25. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
[TBL] [Abstract][Full Text] [Related]
26. Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants.
Mendez I; Sadi D; Hong M
J Neurosci; 1996 Nov; 16(22):7216-27. PubMed ID: 8929430
[TBL] [Abstract][Full Text] [Related]
27. Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.
Borlongan CV; Zhou FC; Hayashi T; Su TP; Hoffer BJ; Wang Y
Neurobiol Dis; 2001 Aug; 8(4):636-46. PubMed ID: 11493028
[TBL] [Abstract][Full Text] [Related]
28. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
29. Behavioral changes associated with grafts of embryonic ventral mesencephalon tissue into the striatum and/or substantia nigra in a rat model of Parkinson's Disease.
Johnston RE; Becker JB
Behav Brain Res; 1999 Oct; 104(1-2):179-87. PubMed ID: 11125737
[TBL] [Abstract][Full Text] [Related]
30. The age of striatum determines the pattern and extent of dopaminergic innervation: a nigrostriatal double graft study.
Strömberg I; Björklund L; Förander P
Cell Transplant; 1997; 6(3):287-96. PubMed ID: 9171161
[TBL] [Abstract][Full Text] [Related]
31. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion.
Zuch CL; Nordstroem VK; Briedrick LA; Hoernig GR; Granholm AC; Bickford PC
J Comp Neurol; 2000 Nov; 427(3):440-54. PubMed ID: 11054705
[TBL] [Abstract][Full Text] [Related]
32. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ
Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221
[TBL] [Abstract][Full Text] [Related]
33. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
[TBL] [Abstract][Full Text] [Related]
34. Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopa.
Blunt SB; Jenner P; Marsden CD
Exp Brain Res; 1992; 88(2):326-40. PubMed ID: 1577107
[TBL] [Abstract][Full Text] [Related]
35. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
36. Dopaminergic reinnervation of the globus pallidus by fetal nigral grafts in the rodent model of Parkinson's disease.
Bartlett LE; Mendez I
Cell Transplant; 2005; 14(2-3):119-27. PubMed ID: 15881421
[TBL] [Abstract][Full Text] [Related]
37. Topology of intrastriatal dopaminergic grafts determines functional and emotional outcome in neurotoxin-lesioned rats.
Jungnickel J; Kalve I; Reimers L; Nobre A; Wesemann M; Ratzka A; Halfer N; Lindemann C; Schwabe K; Töllner K; Gernert M; Grothe C
Behav Brain Res; 2011 Jan; 216(1):129-35. PubMed ID: 20655334
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y
Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412
[TBL] [Abstract][Full Text] [Related]
39. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. II. Transplant-induced behavioral recovery.
Nikkhah G; Cunningham MG; McKay R; Björklund A
J Neurosci; 1995 May; 15(5 Pt 1):3562-70. PubMed ID: 7751930
[TBL] [Abstract][Full Text] [Related]
40. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.
Krobert K; Lopez-Colberg I; Cunningham LA
Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
